YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Avandia
Another Avandia Critic Says Drug Maker Tried To Shut Her Up
Nov 19, 2008 | Parker Waichman Alonso LLP
Another doctor has come forward to claim that the maker of Avandia tried to silence her criticism of the controversial diabetes drug, The...
Avandia Disappoints Again, Doesn't Significantly Reduce Arterial Plaque
Nov 13, 2008 | Parker Waichman Alonso LLP
Avandia, GlaxoSmithKline's controversial diabetes drug, does not reduce arterial plaque buildup in any significant way, according to a new...
New Diabetes Drugs More Expensive, But Not Always Better
Oct 28, 2008 | Parker Waichman Alonso LLP
A new report has found that the cost for treating diabetes has skyrocketed, despite inconclusive evidence that newer, more expensive treatments...
Patients Sue Glaxo Claiming it Suppressed Data on Avandia
Jul 9, 2008 | Parker Waichman Alonso LLP
Two North Carolina patients have sued GlaxoSmithKline claiming its diabetes drug, Avandia, caused their heart attacks. Hundreds more are...
Diabetes Drugs Need Tougher Testing for Heart Risk, FDA Panel Says
Jul 7, 2008 | Parker Waichman Alonso LLP
Last week, a Food & Drug Administration (FDA) advisory panel voted to back tougher testing requirements for diabetes drugs. In a 14-2 vote,...
Avandia Debacle Prompts FDA to Consider New Rules for Approving Diabetes Drugs
Jun 30, 2008 | Parker Waichman Alonso LLP
Federal regulators are mulling over new rules for approving diabetes drugs. The new regulations the Food & Drug Administration (FDA) is...
Ketek, Avandia Among Drugs Doctors Won't Take
Jun 23, 2008 | Parker Waichman Alonso LLP
When doctors were recently asked which commonly prescribed medications they would avoid, they came up with the following eight. Perhaps you...
Outgoing Glaxo Head Says Drugs Should be Tested Sooner, Better
May 20, 2008 | Parker Waichman Alonso LLP
Outgoing head of GlaxoSmithKline (GSK) Jean-Pierre Garnier says the he does not foresee the US Food and Drug Administration (FDA) softening its...
FDA Planning Hiring Blitz
May 1, 2008 | Parker Waichman Alonso LLP
The beleaguered Food & Drug Administration (FDA) is planning on filling over 1,300 positions by the end of September, triple the amount hired by...
Another Study Confirms Avandia, Actos Bone Fracture Risk
Apr 29, 2008 | Parker Waichman Alonso LLP
Avandia, a diabetes drug already mired in controversy, may double the risk of bone fractures, according to a new study. The study, conducted by...
Avandia
